FDA warns against use of Skippack Medical Lab COVID-19 Antigen Test
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
•
May 11, 2022, 10:40 AM
•
Updated 1,272 days ago
Share:
More Stories
Hometown Heroes in Connecticut
565ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
763ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
769ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
775ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
796ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
815ds agoHometown Heroes in Connecticut
565ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
763ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
769ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
775ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
796ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
815ds agoThe
U.S. Food and Drug Administration is warning people not to use the
Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
According to the FDA, the test is not authorized, cleared, or approved by the FDA for distribution or use in the United States.
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
The FDA says it has not received reports of injuries or death associated with use of the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
According to the FDA, the test is not authorized, cleared, or approved by the FDA for distribution or use in the United States.
The FDA is concerned about the risk of false results when using this test because it says SML Distribution LLC has not provided the FDA with adequate data to show the test works correctly.
The FDA says it has not received reports of injuries or death associated with use of the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold).
More from News 12
0:56
Norwalk Conservatory of the Arts offers Wolfpit Elementary sneak peek of 'Footloose'
0:42
UI asks for reconsideration to build a new power line between Bridgeport and Fairfield
1:32
University of New Haven plays first men's basketball game as a Division I program
1:40
Connecticut Humane Society provides tips, resources for pet owners as holiday season approaches
Live Blog: News 12 Connecticut Election Day 2025
2:24
